共 57 条
Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma
被引:50
作者:
Semprucci, E.
[1
]
Tocci, P.
[1
]
Cianfrocca, R.
[1
]
Sestito, R.
[1
]
Caprara, V.
[1
]
Veglione, M.
[1
]
Di Castro, V.
[1
]
Spadaro, F.
[2
]
Ferrandina, G.
[3
]
Bagnato, A.
[1
]
Rosano, L.
[1
]
机构:
[1] Regina Elena Natl Canc Inst Rome, Via Elio Chianesi 53, I-00144 Rome, Italy
[2] Ist Super Sanita, Dept Haematol Oncol & Mol Med, Sect Expt Immunotherapy, Rome, Italy
[3] Univ Cattolica Sacro Cuore, Gynecol Oncol Unit, Rome, Italy
来源:
关键词:
TO-MESENCHYMAL TRANSITION;
CANCER CELLS;
EPITHELIAL CARCINOMA;
ACTIN REORGANIZATION;
PDZ-RHOGEF;
N-WASP;
MIGRATION;
ACTIVATION;
RHOC;
INVASION;
D O I:
10.1038/onc.2015.403
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
The endothelin-1 (ET-1)/ET A receptor (ETAR) signalling pathway is a well-established driver of epithelial ovarian cancer (EOC) progression. One key process promoted by ET-1 is tumor cell invasion, which requires the scaffolding functions of beta-arrestin-1 (beta-arr1) downstream of the receptor; however, the potential role of ET-1 in inducing invadopodia, which are crucial for cellular invasion and tumor metastasis, is completely unknown. We describe here that ET-1/ETAR, through beta-arr1, activates RhoA and RhoC GTPase and downstream ROCK (Rho-associated coiled coil-forming kinase) kinase activity, promoting actin-based dynamic remodelling and enhanced cell invasion. This is accomplished by the direct interaction of beta-arr1 with PDZ-RhoGEF (postsynaptic density protein 95/disc-large/zonula occludens-RhoGEF). Interestingly, ETAR-mediated invasive properties are related to the regulation of invadopodia, as evaluated by colocalization of actin with cortactin, as well as with TKS5 and MT1-MMP (membrane type 1-matrix metalloproteinase) with areas of matrix degradation, and activation of cofilin pathway, which is crucial for regulating invadopodia activity. Depletion of PDZ-RhoGEF, or beta-arr1, or RhoC, as well as the treatment with the dual ET-1 receptor antagonist macitentan, significantly impairs invadopodia function, MMP activity and invasion, demonstrating that beta-arr1/PDZ-RhoGEF interaction mediates ETAR-driven ROCK-LIMK-cofilin pathway through the control of RhoC activity. In vivo, macitentan is able to inhibit metastatic dissemination and cofilin phosphorylation. Collectively, our data unveil a noncanonical activation of the RhoC/ROCK pathway through the beta-arr1/PDZ-RhoGEF complex as a regulator of ETAR-induced motility and metastasis, establishing ET-1 axis as a novel regulator of invadopodia protrusions through the RhoC/ROCK/LIMK/cofilin pathway during the initial steps of EOC invasion.
引用
收藏
页码:3432 / 3442
页数:11
相关论文